USP14: structure, function, and target inhibition
F Wang, S Ning, B Yu, Y Wang - Frontiers in Pharmacology, 2022 - frontiersin.org
Ubiquitin-specific protease 14 (USP14), a deubiquitinating enzyme (DUB), is associated
with proteasomes and exerts a dual function in regulating protein degradation. USP14 …
with proteasomes and exerts a dual function in regulating protein degradation. USP14 …
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
H Gao, J Yin, C Ji, X Yu, J Xue, X Guan… - Journal of Experimental …, 2023 - Springer
Tumors have evolved in various mechanisms to evade the immune system, hindering the
antitumor immune response and facilitating tumor progression. Immunotherapy has become …
antitumor immune response and facilitating tumor progression. Immunotherapy has become …
Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New
drugs are required for ancillary support of existing malaria control efforts. Plasmodium …
drugs are required for ancillary support of existing malaria control efforts. Plasmodium …
Molecular mechanisms of DUBs regulation in signaling and disease
Y Li, D Reverter - International journal of molecular sciences, 2021 - mdpi.com
The large family of deubiquitinating enzymes (DUBs) are involved in the regulation of a
plethora of processes carried out inside the cell by protein ubiquitination. Ubiquitination is a …
plethora of processes carried out inside the cell by protein ubiquitination. Ubiquitination is a …
Discovery of potential HER2 inhibitors from Mangifera indica for the treatment of HER2-Positive breast cancer: an integrated computational approach
Human epidermal growth factor receptor 2 (HER2) is a member of epidermal growth factor
receptors with tyrosine kinase functionality. The dimerization of HER2 leads to the …
receptors with tyrosine kinase functionality. The dimerization of HER2 leads to the …
USP14 promotes colorectal cancer progression by targeting JNK for stabilization
XH Du, SB Ke, XY Liang, J Gao, XX Xie, LZ Qi… - Cell death & …, 2023 - nature.com
MAPK/JNK signaling is pivotal in carcinogenesis. However, ubiquitin-mediated homeostasis
of JNK remains to be verified. Here, with results from RNA sequencing (RNA-seq) and …
of JNK remains to be verified. Here, with results from RNA sequencing (RNA-seq) and …
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment
The ubiquitin-proteasome system (UPS) plays a central role in the degradation of cellular
proteins. Targeting protein degradation has been validated as an effective strategy for …
proteins. Targeting protein degradation has been validated as an effective strategy for …
Discovery of Potential Phytochemicals from Carica papaya Targeting BRCA-1 in Breast Cancer Treatment
A Ibrahim, N Ipinloju, AO Aiyelabegan… - Applied biochemistry …, 2023 - Springer
The BRCA1 and BRCA2 are genes that encode a protein that ensures the integrity of DNA
and prevents the unregulated cells from proliferating. Mutations in the sequence of these …
and prevents the unregulated cells from proliferating. Mutations in the sequence of these …
Structure-based discovery of selective CYP17A1 inhibitors for Castration-resistant prostate cancer treatment
Prostate cancer (PCa) is the most common malignancy found in men and the second
leading cause of cancer-related death worldwide. Castration-resistant PCa (CRPC) is …
leading cause of cancer-related death worldwide. Castration-resistant PCa (CRPC) is …
Discovering potential asthma therapeutics targeting hematopoietic prostaglandin D2 synthase: An integrated computational approach
FM Aldakheel - Archives of Biochemistry and Biophysics, 2024 - Elsevier
Allergic asthma, a chronic inflammatory illness that affects millions worldwide, has serious
economic and health consequences. Despite advances in therapy, contemporary treatments …
economic and health consequences. Despite advances in therapy, contemporary treatments …